Rallybio Corp. (RLYB)
16.64
+0.24
(+1.46%)
USD |
NASDAQ |
Oct 23, 16:00
16.48
-0.16
(-0.96%)
After-Hours: 20:00
Rallybio EPS Diluted (Quarterly) : 7.531 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 7.531 |
| March 31, 2026 | -1.455 |
| December 31, 2025 | -1.108 |
| September 30, 2025 | 2.844 |
| June 30, 2025 | -1.731 |
| March 31, 2025 | -0.2108 |
| December 31, 2024 | -1.978 |
| September 30, 2024 | -0.2571 |
| June 30, 2024 | -0.3679 |
| March 31, 2024 | -0.4667 |
| December 31, 2023 | -0.4981 |
| September 30, 2023 | -0.4533 |
| June 30, 2023 | -0.4616 |
| Date | Value |
|---|---|
| March 31, 2023 | -0.4303 |
| December 31, 2022 | -0.4562 |
| September 30, 2022 | -0.5969 |
| June 30, 2022 | -0.5748 |
| March 31, 2022 | -0.4782 |
| December 31, 2021 | -0.3864 |
| September 30, 2021 | -0.3173 |
| June 30, 2021 | -0.4188 |
| March 31, 2021 | -0.4132 |
| December 31, 2020 | -2.619 |
| September 30, 2020 | -0.306 |
| June 30, 2020 | -0.6474 |
| March 31, 2020 | -0.1208 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | -1.355 |
| Oncolytics Biotech, Inc. | -0.0788 |
| Sangamo Therapeutics, Inc. | -0.0796 |
| Sarepta Therapeutics, Inc. | -0.0464 |
| Anixa Biosciences, Inc. | -0.0762 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 43.66M |
| Total Expenses (Quarterly) | -43.66M |
| Enterprise Value | -4.542M |
| Earnings Yield | 46.95% |
| Normalized Earnings Yield | 14.90 |